EV/EBITDA in the health & pharmaceuticals sector worldwide 2019-2024, by industry
收藏www.statista.com2024-09-09 更新2025-03-26 收录
下载链接：
https://www.statista.com/statistics/1030111/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-worldwide/
下载链接
链接失效反馈官方服务：
资源简介：
Worldwide, the median value of enterprise value to earnings before interest, tax, depreciation and amortization (EV/EBITDA) in the health & pharmaceuticals sector as of 2024, was a multiple of approximately 14.9x. Healthcare information and technology companies saw the highest average valuation multiples as of January 2024 with 21.7x.
全球范围内，截至2024年，健康与制药行业的公司市值与息税折旧摊销前收益（EV/EBITDA）的比值中位数约为14.9倍。截至2024年1月，医疗信息与科技公司见证了最高的平均估值倍数，达到21.7倍。
提供机构：
Statista
